BrainGVEX

syn4590909

Created By Mette Peters Mette

phase: I II
grants: U01MH103340 R01MH110920
tissue: frontal cortex dorsolateral prefrontal cortex
methods: syn7349497 syn3270015 syn5909361 syn17093164 syn26017684 syn26450449 syn26434236
species: Human
dataTypes: Gene Expression Chromatin Activity Proteomics
diagnosis: Bipolar Disorder Schizophrenia
studyType: Individual
studyDescription: The BrainGVEX study explores how genetic variants affect brain gene expression (GVEX) and contribute to neuropsychiatric disease risk by characterizing non-coding regulatory elements in the human brain. Expression QTLs (QTLs), protein QTLs, and chromatin accessibility QTLs are mapped and integrated with data from genome-wide association studies to uncover regulatory mechanisms linking genetic variants and psychiatric disease.
nucleicAcidSource: bulk cell
numberOfIndividuals: 428
contributingInstitution: The State University of New York
syn5613798

BrainGVEX page is loading…